Additionally, as an essential for NF-κB stimulation, RBCK1 mutations are shown to be related to immunodeficiency and tumor-infiltrating immune cells, which proved to be an independent prognostic biomarker in RCC (71, 72). Here, RBCK1 is linked to immune system disorder.